Skip to main content

tofacitinib

NDC 70771-1821 · Zydus Lifesciences Limited

Generic nametofacitinib
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)TOFACITINIB CITRATE
Strength5 mg/1
Pharmacologic classJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
Marketing categoryANDA

Packages

70771-1821-6 — 60 TABLET, FILM COATED in 1 BOTTLE (70771-1821-6)

70771-1821-8 — 180 TABLET, FILM COATED in 1 BOTTLE (70771-1821-8)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70069-841 — TOFACITINIB, 70069-842 — TOFACITINIB, 70095-008 — Tofacitinib, 70377-057 — Tofacitinib, 70710-1243 — tofacitinib, 70710-1353 — tofacitinib, 70710-1589 — tofacitinib, 70710-1727 — tofacitinib, 70771-1627 — tofacitinib, 70771-1628 — tofacitinib, 70771-1967 — tofacitinib, 71085-099 — Tofacitinib, 72205-121 — TOFACITINIB, 72205-139 — Tofacitinib, 72205-140 — Tofacitinib, 73190-100 — Tofacitinib, 73190-101 — Tofacitinib, 73190-102 — tofacitinib, 76282-816 — TOFACITINIB, 76333-111 — TOFACITINIB, +27 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.